fig. S2. Expression levels of unspliced XBP1 (XBP1-u) and spliced XBP1 (XBP1-s).
(A and B) Schematic diagram showing the homology and the difference between nucleotide (A) and amino acid (B) sequences of XBP1-u and XBP1-s. Blue: homologous N terminus; red: XBP1-u C terminus; purple: XBP1-s C terminus. (C) mRNA expression levels of XBP1-u (left) and XBP1-s (right) upon exposure to thapsigargin, as determined using quantitative reverse transcription PCR (qPCR). Cells which were not exposed to thapsigargin were used as control. (D and E) mRNA (D) and protein (E) expression levels of p21 in HCT116 WT cells treated with thapsigargin, as determined by qPCR and western blotting. Cells which were not exposed to thapsigargin were used as control. (F and G) Ratios of the XBP1-u and XBP1-s copy numbers under basal condition (F) or XBP1-silenced HCT116 WT cells (G), as analyzed by qPCR. Copy numbers were obtained using standard curve, and that of XBP1-u in basal condition or HCT116 WT cells transfected with shCon were used as control. -Actin was used for qPCR normalization and as western blotting loading control. Quantitative data are shown as relative to control and expressed as mean ± s.e.m of three independent experiments. **P < 0.01 (ANOVA); p21-luc: p21 reporter vector.
fig. S3. Overexpression of XBP1-u suppresses p21 expression without inducing UPR.
(A and B) mRNA expression levels of XBP1-u (left) and XBP1-s (right) in HCT116 WT cells transfected with pcXBP1-u (A) or pcXBP1-s (B), as quantified by quantitative reverse transcription PCR (qPCR). Cells transfected with pcDNA3.1(+) were used as control. (C) Quantification of the western blot result as shown in Fig. 1D showing the protein expression level of p21 in HCT116 WT or HCT116 XBP1null cells transfected with pcXBP1-u. (D) mRNA expression levels of UPR-related genes ATF4, CHOP and BIP in HCT116 WT cells transfected with pcXBP1-u, as determined by qPCR. Cells transfected with pcDNA3.1(+) were used as control. -Actin was used for normalization. Quantitative data are shown as relative to control, and expressed as mean ± s.e.m of three independent experiments. **P < 0.01; NS: not significant (ANOVA); pcCon: pcDNA3.1(+).
fig. S4. XBP1-u promotes cell cycle progression and cell proliferation. (A)
Total HCT116 XBP1null cell number at indicated time points. (B) Different cell cycle phases of HCT116 XBP1null cells. Cells were stained using propidium iodide. The percentages were determined by flow cytometry, and representative images are shown. (C) Quantification of the western blot result as shown in Fig. 2D . (D and E) Protein expression levels of cyclin D and CDK4 in HCT116 XBP1null (D) and HCT116 WT cells treated with thapsigargin (E), as determined by western blotting. (F and G) Quantification of the western blot result as shown in Fig. 2E . (H) Protein expression levels of cyclin D and CDK4 in HCT116 XBP1null cells transfected with either pcXBP1-u or pcXBP1-s, as determined by western blotting. (I and J) Protein expression levels of cyclin B1, cyclin E and CDK1 in XBP1-silenced HCT116 WT cells, HCT116 XBP1null cells and HCT116 WT cells treated with thapsigargin (I); or in HCT116 WT cells transfected with either pcXBP1-u or pcXBP1-s (J), as determined by western blotting. -Actin was used as loading control. Quantitative data are shown as relative to control (black bars), and expressed as mean ± s.e.m of three independent experiments. *P < 0.05; **P < 0.01; NS: not significant (ANOVA); TG: thapsigargin.
fig. S5. XBP1-u regulates p21 translation p53-dependently. (A) mRNA expression level of p53 in XBP1-silenced HCT116 WT cells and HCT116 XBP1null cells, as determined by quantitative reverse transcription PCR (qPCR). HCT116 WT cells transfected with shCon or HCT116 WT cells were used as control, respectively. (B) Activities of wild-type p21-luc and p21 mut -luc in the indicated cells, as analyzed by dual luciferase reporter assay. HCT116 WT cells cotransfected with shCon and p21-Luc were used as control. (C) Protein expression level of p21 in XBP1-silenced HCT116 p53null cells, as determined by western blotting. Quantification result is shown in right panel. (D and E) Protein expression levels of cyclin D and CDK4 (D) or other cyclins and CDK (E) in XBP1silenced HCT116 p53null cells, as determined by western blotting. -Actin was used for qPCR normalization and as western blotting loading control. Quantitative data are shown as relative to control, and expressed as mean ± s.e.m of three independent experiments. NS: not significant; **P < 0.01 (ANOVA); p21 mut -luc: a luciferase reporter bearing the p21 promoter without the p53-binding site. Protein expression levels of MDM2, p53 and p21 in XBP1-silenced HCT116 WT cells transfected with pcMDM2, as determined by western blotting. (F and G) mRNA expression level of p21 in HCT116 XBP1null /pcMDM2, HCT116 XBP1null /pcDNA3 and HCT116 WT /pcDNA3 stable cell lines, as determined by quantitative reverse transcription PCR (qPCR) (F); and the total cell number of each stable cell lines at indicated time points (G). qPCR data are shown as relative to HCT116 WT /pcDNA3 cells. Quantitative data are expressed as mean ± s.e.m of three independent experiments. **P < 0.01 versus HCT116 XBP1null /pcDNA3 (ANOVA). -Actin was used for qPCR normalization and as western blotting loading control. pcCon: pcDNA3.1(+). fig. S9. p53 feedback mechanism restores XBP1-u regulation on the MDM2 mRNA expression level. (A and B) mRNA expression level of MDM2 in XBP1-silenced (left) or XBP1-knockout (right) HCT116 cells (A), and in HCT116 WT cells transfected with pcXBP1-u (B), as determined by quantitative reverse transcription PCR (qPCR). Cells transfected with shCon or pcCon were used as controls, respectively. (C) Activities of p53-irresponsive (p1) and p53-responsive (p2) MDM2 promoter reporter vectors (left and right, respectively) in XBP1-silenced HCT116 WT cells, as analyzed by dual luciferase reporter assay. Cells transfected with shCon were used as control. (D) mRNA expression levels of XBP1 and MDM2 in XBP1-silenced HCT116 p53null cells, as quantified by qPCR. Cells transfected with shCon were used as control. (E) Activity of p53-responsive (p2) MDM2 promoter reporter vector in XBP1-silenced HCT116 p53null cells, as analyzed by dual luciferase reporter assay. Cells transfected with shCon were used as control. -Actin was used for qPCR normalization. Quantitative data are shown as relative to control and expressed as mean ± s.e.m of three independent experiments. **P < 0.01 (ANOVA); NS: not significant; pcCon: pcDNA3.1(+). Cell lysate was immunoprecipitated using anti-FLAG antibody, and the immunoprecipitant was further immunoprecipitated using anti-MDM2 antibody prior being subjected to immunoblotting using indicated antibodies. IP: immunoprecipitation; IB: immunoblotting.
fig. S12. XBP1-u does not interact with MDMX. HCT116 WT cells were transfected with pcFLAG-MDMX and pcMDM2 (left), or pcFLAG-MDMX and pcXBP1-u (right), and the presence of FLAG-MDMX was detected by immunoblotting against FLAG for the cell lysate immunoprecipitated with anti-MDM2 antibody (left) or anti-XBP1 antibody (right), respectively. IP: immunoprecipitation; IB: immunoblotting. 
